Characteristic Overall (519)
Age (Years) 66.9±13.2
Genere, Male 387 (74.7%)
IHD 173 (33.3%)
PTCA 99 (19.1%)
CABG 35 (6.7%)
Valvular Desease 46 (8.9%)
AF at Implant 58 (11.2%)
AF History 126 (24.3%)
LVEF 29.6±11.7
CRT-D device 201 (38.8%)
SCD for Secondary Prevention 108 (20.8%)
COPD 148 (28.5%)
CKD 55 (10.6%)
Hypertension 275 (53.0%)
Diabetes 110 (21.2%)
Beta-blockers 454 (87.4%)
ACEI’s 225 (43.4%)
Angiotensin Receptor Blockers, Sartanics 126 (24.3%)
Valsartan/sacubitril, Entresto 97 (18.7%)
Diuretics 410 (79.0%)
NOACs 223 (42.9%)